When Not to Intervene in Acute Stroke or

Slides:



Advertisements
Similar presentations
3/28/2017© 2009, American Heart Association. All rights reserved.
Advertisements

STROKE UPDATE Carlos S. Kase, M.D. Department of Neurology Boston Medical Center Medicine Grand Rounds New England Baptist Hospital March 17, 2011.
Accomplishments in Stroke Care
TPA in Stroke: What's All the Fuss?. FERNE Brain Illness and Injury Course.
Some Difficult Stroke Cases: What Would You Do?
The NINDS rt-PA Stroke Trial Prior information(Pre-Clinical, Phase I Studies, etc) Thrombolytic canalization of occluded arteries may reduce the degree.
TPA… SMART or not SMART? That is the Question. Sarah Parker, MD.
Hyperacute Stroke Treatment: Inclusion and Exclusion Criteria
Disclosures: Maximo C. Kiok, M.D. Medical Director of Stroke Program Trinity Health System.
EM TREATMENT OF ACUTE STROKE Progress, Problems, Politics William G. Barsan, M.D. University of Michigan.
J. Stephen Huff, MD ED Stroke Patient Management: What must we be able to do in order to provide tPA in the ED? (mimics, stroke scales, timing, and CT.
Clinical Use of tPA in Acute Ischemic Stroke Edward P. Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois College.
Andrew W. Asimos, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Maximizing IV Thrombolytic Therapy in Acute Ischemic Stroke Kamakshi Lakshminarayan, MD PhD Assistant Professor Neurology & Epidemiology University of.
J. Stephen Huff, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
E. Bradshaw Bunney, MD Stroke Care within the 3 Hour IV tPA Window: Why IV tPA, or What Alternatives?
Ischemic Stroke Time is Brain: Or Is It?
E. Bradshaw Bunney, MD Acute Ischemic Stroke Update.
Thrombolysis and Beyond: The New Therapeutic Horizons for Acute Ischemic Stroke
TPA in Acute Ischemic Stroke: The NINDS Reanalysis & Meta-analysis Data Sidney Starkman, MD, FACEP.
Andrew W. Asimos, MD How Can We Use Advanced Neuroimaging in the ED to Optimize Treatment Options for Acute Stroke Patients?
T-PA in Treatment of Acute Stroke: What We Know From NINDS 2004 vs 2000 Sidney Starkman, MD Departments of Emergency Medicine and Neurology, UCLA UCLA.
FERNE/MEMC Session: Treating Ischemic Stroke in the 3 – 4
Edward P. Sloan, MD, MPH FERNE/EMA Session: Treating Ischemic Stroke Patients Using a 3 to 4.5 Hour tPA Window.
Clinical Use of tPA in Acute Ischemic Stroke. Edward P. Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois College.
Clinical Use of tPA in Acute Ischemic Stroke Edward P. Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois College.
2015 Joint Congress on Medical Imaging and Radiation Sciences Imaging and Intervention in Acute Stroke: MR Imaging in Acute Stroke Viesha Ciura, MD, FRCPC.
Interventions in Acute Ischemic Stroke: Strategies for the New Millennium For the next 25 minutes, we will spend sometime talking about Neuroimaging.
Maximizing IV Thrombolytic Therapy in Acute Ischemic Stroke Kamakshi Lakshminarayan, MD PhD Assistant Professor Neurology & Epidemiology University of.
Thrombolysis in acute ischaemic stroke – Updated Cochrane Thrombolysis metaanalysis JM Wardlaw, V Murray, PAG Sandercock University of Edinburgh and Karolinska.
Evidence in the ED Byron Drumheller, MD Penn Emergency Medicine.
Overview of new acute stroke trials Shawna Cutting, MD, MS Rush University Medical Center June 9, 2015.
Intra - Arterial Thrombolysis for acute stroke
Andrew W. Asimos, MD How Can We Use Advanced Neuroimaging in the ED to Optimize Treatment Options for Acute Stroke Patients?
S afe I mplementation of T hrombolysis in S troke Slide presentation adapted from
The Use of tPA in Acute Ischemic Stroke Edward P. Sloan, MD, MPH Professor Department of Emergency Medicine University of Illinois College of Medicine.
Stroke : To Lyse or Not to Lyse ? Understand the Literature and Decide : What is best for your practice environment ?
Clinical Use of tPA in Acute Ischemic Stroke Edward P. Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois College.
XIX Symposium Neuroradiologicum
before thrombolysis in acute stroke
Kim, Sun-Yong, M.D. Department of Radiology Ajou University Hospital, Suwon, Korea AGGRESIVE MECHANICAL CLOT DISRUPTION FOR ACUTE ISCHEMIC STROKE WITH.
Time Is Brain: Advanced Stroke Treatment Grahame C Gould, MD Jefferson Neurosurgical Associates at Main Line Health, Bryn Mawr Hospital Division of Neurovascular.
Brain waves or brain drain Interactive case discussion Dr Jenny Vaughan and Dr Richard Perry Charing Cross Hospital Hammersmith Hospital Imperial College.
ACUTE STROKE TREATMENT: An introduction Dec.2014
Ischemic Stroke 2010 and the Future
Acute Ischemic Stroke: Introduction to Diagnosis and Treatment
Treating Acute Ischemic Stroke, Can We Open Up the Time Window?
ACUTE ISCHEMIC STROKE Olajide Williams, MD MS.
Table 1: Table 2: Non Therapeutic Angiograms in Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment Does not Adversely Affect Patient.
Erik Oltmann, PGY-1 August 20, 2015
Thrombectomy in Acute Stroke
Sameer A. Ansari, MD, PhD Associate Professor
Acute Stroke Therapy with IV Thrombolysis Lawrence R. Wechsler, M.D.
CRT 2010 Imaging Requirements and Interpretation in Acute Stroke
Cardiovascular Research Technology Conference (CRT 17)
STROKE Afifah Machlaurin.
Olivier Bill1,3, Nuno M Inácio2, Dimitrios Lambrou1, Patrik Michel1.
Acute Ischemic Stroke Yousef Mohammad MD., MSc., FAHA
Icahn School of Medicine Mount Sinai Hospital
Setareh Omran, MD Vascular Neurology Fellow
Performance Improvement: Emergency Management in Acute Cerebrovascular Patients Current US Guidelines Lisa A. Shultz, MD Medical Director, Lourdes Stroke.
The New Frontier In Stroke Care – Endovascular Intervention
Acute Ischemic Stroke First Eight Hours Dr. Mohammed Ateequr Rahman
Modified Rankin score 0-2
Acute Stroke Slide Kit August 2017.
The Role of Induced Hypertension and Hyperbaric Oxygen Therapy in Moyamoya Disease: A Case Report Smeer Salam, MD; Lisa Pabst, MD; Sushil Lakhani, MD;
Extended Window Thrombectomy
Update from education committee
Tissue Plasminogen Activator 20 Years Later
Presentation transcript:

When Not to Intervene in Acute Stroke or Primum non nocere Lawrence R. Wechsler, M.D. Professor and Chair, Department of Neurology University of Pittsburgh

Lawrence R. Wechsler, MD Ownership Interest (Stocks, Stock Options or Ownership Interest) Neuro Interventional Therapeutic

When Not to Intervene Undesirable Outcomes No recanalization 9 10 11 12 7 8 6 5 1 2 3 4 Control Undesirable Outcomes No recanalization No improvement Massive cerebral edema Hemorrhage

Exclusions for IV tPA Stroke mimics Mild stroke – non disabling (VF deficit, aphasia) ? Severe stroke NIHSS > 20 Rapidly resolving deficits BP > 185 systolic > 110 diastolic INR > 1.7, Platelets < 100K Seizure at onset Glucose < 50 or > 400 mg/dl

Additional Exclusions for IV tPA 3-4.5 Hrs – ECASS III Age > 80 Severe stroke – NIHSS > 25 Any anticoagulant use regardless of INR Prior history of stroke and diabetes Hacke W et al. N Engl J Med. 2008;359:1317

Symptomatic Hemorrhage After IV tPA Community Hospital Experience Tanne et al. Neurology 1999:53;424-427

Timing of Sx Hem after IV tPA 8 6 4 2 NINDS tPA Stroke Study Group Stroke 1997;28:2109

NINDS rt-PA Stroke Study Risk of Symptomatic ICH NINDS tPA Stroke Study Group Stroke 1997;28:2109

When Not to Intervene – Time to Rx IV tPA > 3 hrs or > 4.5 Hrs in selected pts IA thrombolytics > 6 hrs IA devices > 9 hrs Basilar thrombosis > 12 hrs Wake-up strokes Clock v. physiology

DEFUSE: Mismatch associated with good outcomes following reperfusion Before tPA NIHSS 16 6 cc 4.5 hrs After tPA NIHSS 5 Improved 0 cc IV tPA 3 cc 65 cc ↓ M2 Flow

The Malignant Mismatch Pattern Before tPA >100 cc M1 open 77 cc 4 hr after tPA 105 cc 215 cc M1 Occlusion

Malignant Pattern Outcomes Modified Rankin Scale at Day 30 0-1 4-6 Malignant Pattern n=6 33 33 83 33 17 0-1 2-3 4-6 p=0.06 All other Patterns n=68 12 12 57 19 31 28 41 All fatal ICHs in malignant pattern patients with early reperfusion; n = 3 No SICH occurred in malignant patient without early reperfusion; 1 patient (45 yrs) had a favorable outcome (Rankin 1) Albers GW et al. Ann Neurol. 2006;60(5):508

Pooled Data: DEFUSE / EPITHET Optimal definition of malignant pattern: PWI Tmax > 8 Sec at least 85cc Large PWI lesion better predictor of poor outcome than large DWI lesion Poor Outcome: Rankin 5-6 Reperfusion No Reperfusion p value Malignant Pattern 88% (7/8) 41% (7/17) 0.04 Non Malignant Pattern 10% (5/56) 33% (7/28) 0.09 De Silva, et al on behalf of the DEFUSE-EPITHET Investigators. ISC 2010

CT Perfusion Irreversible Infarction MTT CBV CBF CT

Summary Severe deficits only relative contraindication Hemorrhage after IV tPA associated with protocol deviations Large established infarction predicts hemorrhage and poor outcome